Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by the aggregation of α-synuclein in the brain. Now, scientists from Japan, in collaboration with three pharmaceutical companies, have developed ...
Aug 30, 2022
0
104
A Cornell University-led collaboration has used machine learning to pinpoint the most accurate means and timelines for anticipating the advancement of Alzheimer's disease in people who are either cognitively normal or experiencing ...
Nov 23, 2022
0
55
A combination of drugs will be needed to effectively treat or prevent Alzheimer's disease and leading experts say we have entered a new era of drug development that will deliver them. In an editorial published in the Journal ...
Jul 6, 2022
0
21
Among patients with mild or no cognitive impairment, brain scans using a new radioactive dye can detect early evidence of Alzheimer's disease that may predict future decline, according to a multi-center study led by researchers ...
Jul 11, 2012
0
0
(HealthDay)—New treatment options are giving hope to patients with stomach cancer.
Nov 25, 2021
0
14
A team of researchers affiliated with several institutions in the U.S. and one in the U.K. has developed a new type of Cerenkov luminescence imaging device to help doctors spot cancerous tumors. In their paper published in ...
Using strong and targeted but noninvasive magnets at specific sites in the brains of people with and without mild learning and memory problems, Johns Hopkins researchers report they were able to detect differences in the ...
Mar 19, 2019
0
269
(Medical Xpress)—New research suggests that the molecular mechanism leading to schizophrenia may be different in patients who fail to respond to anti-psychotic medication compared to patients who do respond.
Nov 29, 2012
0
0
Suddenly getting lost, failing to recognize family members, or forgetting words and names are well-known symptoms of Alzheimer's disease. Psychologists have now discovered that the disease also manifests in more subtle ways: ...
Sep 20, 2023
0
56
Biomarkers—measurable physical signs of a condition—could be a useful way of testing for Alzheimer's disease, according to a new review study.
Apr 27, 2020
0
281
